Reslizumab improves asthma control, symptoms, lung function – Healio

Reslizumab improves asthma control, symptoms, lung function
Healio
“Intravenous reslizumab [Cinqair, Teva Respiratory] 3.0 mg/kg provided improvements in lung function, asthma symptoms, and quality of life for patients with inadequately controlled asthma and elevated blood eosinophils (? 400 cells/µL) that were

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *